Cisplatin Disrupts the Latency of Human Herpesvirus 8 and Induces Apoptosis in Primary Effusion Lymphoma Cells

Yi-Fen WangDepartment of Medical Laboratory Sciences and Biotechnology, Fooyin-University, Kaohsiung, Taiwan, ROC,Correspondence[email protected]

Yee-Hsuan ChiouDepartment of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC

Lin-Yu WangDepartment of Medical Laboratory Sciences and Biotechnology, Fooyin-University, Kaohsiung, Taiwan, ROC,

Su-Ting ChangDepartment of Medical Laboratory Sciences and Biotechnology, Fooyin-University, Kaohsiung, Taiwan, ROC,

Huey-Wen ShyuDepartment of Medical Laboratory Sciences and Biotechnology, Fooyin-University, Kaohsiung, Taiwan, ROC,

Chang-Yu ChenDepartment of Medical Laboratory Sciences and Biotechnology, Fooyin-University, Kaohsiung, Taiwan, ROC,

Kuan-Hua LinDepartment of Medical Laboratory Sciences and Biotechnology, Fooyin-University, Kaohsiung, Taiwan, ROC,

Miao-Chen ChouDepartment of Medical Laboratory Sciences and Biotechnology, Fooyin-University, Kaohsiung, Taiwan, ROC,

show all

Abstract

Human herpesvirus 8 (HHV8) is the etiologic agent for primary effusion lymphoma (PEL). The aim of this study is to investigate the effects of cisplatin on the PEL cells. Cisplatin treatment induced apoptosis and inhibited the growth of PEL cells, and the effect was more profound in the HHV8-positive lymphoma cells compared with the EBV-positive lymphoma cells. Cisplatin treatment decreased the expression of HHV8 latent genes and activated p53 at serine 15 in PEL cells. Our results indicate that cisplatin can disrupt HHV8 latency and induce reactivation of p53 and highly selective treatment modality for this virally induced lymphoma.

Keywords: :

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Cisplatin Disrupts the Latency of Human Herpesvirus 8 and Induces Apoptosis in Primary Effusion Lymphoma Cells

Information for

Open access

Opportunities

Help and information

Cisplatin Disrupts the Latency of Human Herpesvirus 8 and Induces Apoptosis in Primary Effusion Lymphoma Cells

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature